Associations of roxadustat with copper elevation and hypothyroidism in patients on hemodialysis
Roxadustat may decrease serum TSH, free-T3, and free-T4 levels and increase serum copper and ceruloplasmin levels in HD patients.
Authors
- Keiichi Hirao
- Shunsuke Yoshida
- Keigo Shibagaki
- Tomohiro Saito (ORCID: https://orcid.org/0000-0003-2303-5401)
- Toshiki Yuza
- Hirokazu Honda (ORCID: https://orcid.org/0000-0002-5634-6145)
- Shugo Aoki
Institutions
- SHOWA Medical University (JP)
Publication Details
- Journal
- International Urology and Nephrology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1007/s11255-025-04759-w
- Citations
- 5
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 17.47